Loading
Acclinate
Acclinate is a digital health equity company based in Birmingham, Alabama, founded in 2020. The company focuses on increasing diverse representation in clinical trials and genomic research through artificial intelligence and community engagement. Its mission is to empower communities to improve health outcomes while ensuring that clinical trials reflect real-world diversity. Acclinate operates a dual-platform approach with a national network of over 200,000 members. The NOWINCLUDED community platform facilitates health education and engagement for underrepresented populations, particularly communities of color. The e-DICT technology platform uses patented AI/ML software to automate the identification, education, engagement, and retention of diverse clinical trial participants. Acclinate serves the biopharmaceutical and healthcare sectors, helping organizations meet diversity goals and enhance inclusivity in their research efforts.
Funding
Every round, secondary, debt facility or acquisition involving Acclinate that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$7M